
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Malar.
Sec. Case Management
Volume 3 - 2025 | doi: 10.3389/fmala.2025.1497613
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Controlled human malaria infection (CHMI) studies are considered a powerful tool for assessing the efficacy of malaria vaccines and investigating immunity against infection. The monitoring of infection has historically been carried out by microscopy and/or more recent-ly sensitive quantitative polymerase chain reaction (qPCR) based on the 18S ribosomal RNA (rRNA) gene. Here we describe the validation of a molecular assay previously developed to quantify malaria parasites in CHMI.Methods: We used primers and probes for the 18S rRNA Plasmodium falciparum gene. The val-idation of the assay was performed using cultured 3D7 parasites to generate standards of known quantities of parasites. We determined the specificity, accuracy, precision, lower limit of detec-tion, linearity, and robustness. We also evaluated the effect of using different volumes of whole blood for DNA extraction on the assay performance. Results: The validation revealed: (1) specificity of 100% (n=5 independent experiments); (2) linearity with R2 values ≥ 0.98, a slope of-3.8 to -3.1 and efficiency 89-100%; (3) lower limit of detection of 2.5 parasites/microliters and limit of quantification; (4) precision with both inter-assay repeatability and intra-assay reproducibility had coefficients of variation (CV) values of <10%; and (5) accuracy and good extraction efficiency of >90%. The use of large blood vol-umes for extraction had an adverse effect on precision.Conclusion: We show that this qPCR method for P. falciparum parasite quantification from whole blood is specific, precise, sensitive, accurate and robust. However, our whole blood qPCR method is not suitable when DNA extraction is from large blood volumes, where using a larger extraction volume of 1000 µl has a considerable effect on the robustness, reproducibility, and repeatability of qPCR. Other qPCR methods should be considered where high volumes of blood are required.
Keywords: CHMI, P. falciparum, 18S qPCR, whole blood, Parasite Quantification, assay validation
Received: 17 Sep 2024; Accepted: 04 Mar 2025.
Copyright: © 2025 Kibwana, Kimani, Edwards, Keter, Mutiso, Nyamako, Gatheru, Hill, Bejon, Ewer and Kapulu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Melissa Chola Kapulu, KEMRI Wellcome Trust Research Programme, Kilifi, Kenya
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.